Please enable JavaScript to use this page!

Certican® relaunch

Client

Novartis

Therapeutical Area

Transplantation

Brief

Everolimus is the 40-O-(2-hydroxyethyl) derivative of sirolimus and works as an inhibitor of mammalian target of rapamycin (mTOR). It is currently used as an immunosuppresant to prevent rejection of organ transplants. Certican® a heavyweight in the defense of life. Lungs, heart, kidneys, liver work hard in the battle for life. Campaign won best Integrated campaign to physician.

We did

Creativity // Medical Writing // Audiovisual // Digital // Events

novartis-logo